Counterfeit Drug Furoxime Suspension

DRAP Issues Alert on Fake Antibiotic Drug Furoxime Suspension 100mg/5ml

ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has issued an urgent alert regarding the circulation of a fake antibiotic drug, Furoxime Suspension 100mg/5ml, in the market, as reported by ARY News.

Following testing at the Drug Testing Laboratory in Rawalpindi, the product was confirmed to be counterfeit and substandard.

The packaging of this fraudulent drug features a fake address in Karachi, further complicating the identification and tracking of its source.

Health Risks and Regulatory Actions

The use of this counterfeit drug poses significant health risks, potentially causing severe adverse reactions in patients. In response, DRAP has mandated the immediate confiscation of Furoxime Suspension stocks from the market. Any remaining inventory must be quarantined without delay, and detailed supplier information must be submitted to the Regulatory Field Force, including DRAP, Provincial, and State Drug Control Administrations. This coordinated effort aims to ensure the swift removal of the fake product from circulation.

Consumer Guidance

DRAP has advised consumers to cease using Furoxime Suspension 100mg/5ml immediately. Patients who have taken this drug and are experiencing adverse effects should contact their healthcare provider promptly. Additionally, incidents related to the use of this drug should be reported to the Drug Regulatory Authority of Pakistan or the National Pharmacovigilance Centre to aid in addressing this public health issue.

For more information or to report a problem, individuals can reach out to the National Pharmacovigilance Centre at DRAP.

---

Sources:

- ARY News

- Drug Regulatory Authority of Pakistan